4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-024902
CHIEF SCIENTIFIC OFFICER sold 10,229 shares at an average $27.54 ($281,664)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/form4-10082024_101021.xml…